The regulation of hydroxysteroid 17β-dehydrogenase type 1 and 2 gene expression in breast cancer cell lines by estradiol, dihydrotestosterone, microRNAs, and genes related to breast cancer
To investigate the influence of estrogen, androgen, microRNAs, and genes implicated in breast cancer on the expression of HSD17B1 and HSD17B2. Breast cancer cell lines ZR-75-1, MCF7, T47D, SK-BR-3, and the immortalized epithelial cell line MCF10A were used. Cells were treated either with estradiol o...
Gespeichert in:
Veröffentlicht in: | ONCOTARGET 2017-09, Vol.8 (37), p.62183-62194 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 62194 |
---|---|
container_issue | 37 |
container_start_page | 62183 |
container_title | ONCOTARGET |
container_volume | 8 |
creator | Hilborn, Erik Stål, Olle Alexeyenko, Andrey Jansson, Agneta |
description | To investigate the influence of estrogen, androgen, microRNAs, and genes implicated in breast cancer on the expression of HSD17B1 and HSD17B2.
Breast cancer cell lines ZR-75-1, MCF7, T47D, SK-BR-3, and the immortalized epithelial cell line MCF10A were used. Cells were treated either with estradiol or dihydrotestosterone for 6, 24, 48 hours, or 7 days or treated with miRNAs or siRNAs predicted to influence HSD17B expression Results and discussion. Estradiol treatment decreased
expression and had a time-dependent effect on
. This effect was lost in estrogen receptor-α down-regulated or negative cell lines. Dihydrotestosterone treatment increased
expression, with limited effect on
expression. No effect was seen in cells without AR or in combination with the AR inhibitor hydroxyflutamide. The
up-regulated
, while
and
had up- and down-regulatory effect and
reduced
expression. The
and
reduced
expression. Downregulation of CX3CL1, EPHB6, and TP63 increased
and
, while
downregulation suppressed
and promoted
expression.
We show that
and
are controlled by estradiol, dihydrotestosterone, and miRNAs, as well as modulated by several breast cancer-related genes, which could have future clinical applications. |
doi_str_mv | 10.18632/oncotarget.19136 |
format | Article |
fullrecord | <record><control><sourceid>proquest_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_swepub_ki_se_493602</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1947614580</sourcerecordid><originalsourceid>FETCH-LOGICAL-c432t-feeafece96ce1fbce66711ebbd73890d15514eca91b0e1c87bb6a8f4a04c5ffa3</originalsourceid><addsrcrecordid>eNp9ks9u1DAQxiMEolXpA3BBPnLYlEziOPEFadXyT6pAQoWr5diTXUPWXmwHmtfizivwTHizS-le8MXW-JvfjD59WfYUigtoWVW-cFa5KP0K4wVwqNiD7BQ45XlZ19XDe--T7DyEL0U6NW3akj_OTsqWNw2v2Gn262aNxONqHGQ0zhLXk_WkvbudQkTvjCbQ_P6Za5yrK7QyIInTFgkQaTUpSaohwdutxxB2BGNJ51GGSJS0Cj1ROAxkMBYD6SaCIXqpjRsWRJsZGlPJzdMsLsjGKO8-vl-Gxczf0UNaMK2HmkR3zH6SPerlEPD8cJ9ln16_url8m19_ePPucnmdK1qVMe8RZY8KOVMIfaeQsQYAu043VcsLDXUNFJXk0BUIqm26jsm2p7Kgqu57WZ1l-Z4bfuB27MTWm430k3DSiEPpa3qhoMnUovyv_sp8XgrnV2IwowAKUBZJ_3KvT-INaoU2mTQctR3_WLMWK_dd1AwaylkCPD8AvPs2JkPFxoSd8dKiG4NIYWgY0LrdzYK9NPkcgsf-bgwUYk6W-JcsMScr9Ty7v99dx98cVX8Ak93VQg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1947614580</pqid></control><display><type>article</type><title>The regulation of hydroxysteroid 17β-dehydrogenase type 1 and 2 gene expression in breast cancer cell lines by estradiol, dihydrotestosterone, microRNAs, and genes related to breast cancer</title><source>SWEPUB Freely available online</source><source>PubMed Central Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Free E- Journals</source><creator>Hilborn, Erik ; Stål, Olle ; Alexeyenko, Andrey ; Jansson, Agneta</creator><creatorcontrib>Hilborn, Erik ; Stål, Olle ; Alexeyenko, Andrey ; Jansson, Agneta</creatorcontrib><description>To investigate the influence of estrogen, androgen, microRNAs, and genes implicated in breast cancer on the expression of HSD17B1 and HSD17B2.
Breast cancer cell lines ZR-75-1, MCF7, T47D, SK-BR-3, and the immortalized epithelial cell line MCF10A were used. Cells were treated either with estradiol or dihydrotestosterone for 6, 24, 48 hours, or 7 days or treated with miRNAs or siRNAs predicted to influence HSD17B expression Results and discussion. Estradiol treatment decreased
expression and had a time-dependent effect on
. This effect was lost in estrogen receptor-α down-regulated or negative cell lines. Dihydrotestosterone treatment increased
expression, with limited effect on
expression. No effect was seen in cells without AR or in combination with the AR inhibitor hydroxyflutamide. The
up-regulated
, while
and
had up- and down-regulatory effect and
reduced
expression. The
and
reduced
expression. Downregulation of CX3CL1, EPHB6, and TP63 increased
and
, while
downregulation suppressed
and promoted
expression.
We show that
and
are controlled by estradiol, dihydrotestosterone, and miRNAs, as well as modulated by several breast cancer-related genes, which could have future clinical applications.</description><identifier>ISSN: 1949-2553</identifier><identifier>EISSN: 1949-2553</identifier><identifier>DOI: 10.18632/oncotarget.19136</identifier><identifier>PMID: 28977936</identifier><language>eng</language><publisher>United States: Impact Journals LLC</publisher><subject>Research Paper</subject><ispartof>ONCOTARGET, 2017-09, Vol.8 (37), p.62183-62194</ispartof><rights>Copyright: © 2017 Hilborn et al. 2017</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c432t-feeafece96ce1fbce66711ebbd73890d15514eca91b0e1c87bb6a8f4a04c5ffa3</citedby><cites>FETCH-LOGICAL-c432t-feeafece96ce1fbce66711ebbd73890d15514eca91b0e1c87bb6a8f4a04c5ffa3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617496/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617496/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,552,727,780,784,885,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28977936$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-141120$$DView record from Swedish Publication Index$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:136597931$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Hilborn, Erik</creatorcontrib><creatorcontrib>Stål, Olle</creatorcontrib><creatorcontrib>Alexeyenko, Andrey</creatorcontrib><creatorcontrib>Jansson, Agneta</creatorcontrib><title>The regulation of hydroxysteroid 17β-dehydrogenase type 1 and 2 gene expression in breast cancer cell lines by estradiol, dihydrotestosterone, microRNAs, and genes related to breast cancer</title><title>ONCOTARGET</title><addtitle>Oncotarget</addtitle><description>To investigate the influence of estrogen, androgen, microRNAs, and genes implicated in breast cancer on the expression of HSD17B1 and HSD17B2.
Breast cancer cell lines ZR-75-1, MCF7, T47D, SK-BR-3, and the immortalized epithelial cell line MCF10A were used. Cells were treated either with estradiol or dihydrotestosterone for 6, 24, 48 hours, or 7 days or treated with miRNAs or siRNAs predicted to influence HSD17B expression Results and discussion. Estradiol treatment decreased
expression and had a time-dependent effect on
. This effect was lost in estrogen receptor-α down-regulated or negative cell lines. Dihydrotestosterone treatment increased
expression, with limited effect on
expression. No effect was seen in cells without AR or in combination with the AR inhibitor hydroxyflutamide. The
up-regulated
, while
and
had up- and down-regulatory effect and
reduced
expression. The
and
reduced
expression. Downregulation of CX3CL1, EPHB6, and TP63 increased
and
, while
downregulation suppressed
and promoted
expression.
We show that
and
are controlled by estradiol, dihydrotestosterone, and miRNAs, as well as modulated by several breast cancer-related genes, which could have future clinical applications.</description><subject>Research Paper</subject><issn>1949-2553</issn><issn>1949-2553</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>D8T</sourceid><recordid>eNp9ks9u1DAQxiMEolXpA3BBPnLYlEziOPEFadXyT6pAQoWr5diTXUPWXmwHmtfizivwTHizS-le8MXW-JvfjD59WfYUigtoWVW-cFa5KP0K4wVwqNiD7BQ45XlZ19XDe--T7DyEL0U6NW3akj_OTsqWNw2v2Gn262aNxONqHGQ0zhLXk_WkvbudQkTvjCbQ_P6Za5yrK7QyIInTFgkQaTUpSaohwdutxxB2BGNJ51GGSJS0Cj1ROAxkMBYD6SaCIXqpjRsWRJsZGlPJzdMsLsjGKO8-vl-Gxczf0UNaMK2HmkR3zH6SPerlEPD8cJ9ln16_url8m19_ePPucnmdK1qVMe8RZY8KOVMIfaeQsQYAu043VcsLDXUNFJXk0BUIqm26jsm2p7Kgqu57WZ1l-Z4bfuB27MTWm430k3DSiEPpa3qhoMnUovyv_sp8XgrnV2IwowAKUBZJ_3KvT-INaoU2mTQctR3_WLMWK_dd1AwaylkCPD8AvPs2JkPFxoSd8dKiG4NIYWgY0LrdzYK9NPkcgsf-bgwUYk6W-JcsMScr9Ty7v99dx98cVX8Ak93VQg</recordid><startdate>20170922</startdate><enddate>20170922</enddate><creator>Hilborn, Erik</creator><creator>Stål, Olle</creator><creator>Alexeyenko, Andrey</creator><creator>Jansson, Agneta</creator><general>Impact Journals LLC</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>ABXSW</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>D8T</scope><scope>DG8</scope><scope>ZZAVC</scope></search><sort><creationdate>20170922</creationdate><title>The regulation of hydroxysteroid 17β-dehydrogenase type 1 and 2 gene expression in breast cancer cell lines by estradiol, dihydrotestosterone, microRNAs, and genes related to breast cancer</title><author>Hilborn, Erik ; Stål, Olle ; Alexeyenko, Andrey ; Jansson, Agneta</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c432t-feeafece96ce1fbce66711ebbd73890d15514eca91b0e1c87bb6a8f4a04c5ffa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Research Paper</topic><toplevel>online_resources</toplevel><creatorcontrib>Hilborn, Erik</creatorcontrib><creatorcontrib>Stål, Olle</creatorcontrib><creatorcontrib>Alexeyenko, Andrey</creatorcontrib><creatorcontrib>Jansson, Agneta</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>SWEPUB Linköpings universitet full text</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Freely available online</collection><collection>SWEPUB Linköpings universitet</collection><collection>SwePub Articles full text</collection><jtitle>ONCOTARGET</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hilborn, Erik</au><au>Stål, Olle</au><au>Alexeyenko, Andrey</au><au>Jansson, Agneta</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The regulation of hydroxysteroid 17β-dehydrogenase type 1 and 2 gene expression in breast cancer cell lines by estradiol, dihydrotestosterone, microRNAs, and genes related to breast cancer</atitle><jtitle>ONCOTARGET</jtitle><addtitle>Oncotarget</addtitle><date>2017-09-22</date><risdate>2017</risdate><volume>8</volume><issue>37</issue><spage>62183</spage><epage>62194</epage><pages>62183-62194</pages><issn>1949-2553</issn><eissn>1949-2553</eissn><abstract>To investigate the influence of estrogen, androgen, microRNAs, and genes implicated in breast cancer on the expression of HSD17B1 and HSD17B2.
Breast cancer cell lines ZR-75-1, MCF7, T47D, SK-BR-3, and the immortalized epithelial cell line MCF10A were used. Cells were treated either with estradiol or dihydrotestosterone for 6, 24, 48 hours, or 7 days or treated with miRNAs or siRNAs predicted to influence HSD17B expression Results and discussion. Estradiol treatment decreased
expression and had a time-dependent effect on
. This effect was lost in estrogen receptor-α down-regulated or negative cell lines. Dihydrotestosterone treatment increased
expression, with limited effect on
expression. No effect was seen in cells without AR or in combination with the AR inhibitor hydroxyflutamide. The
up-regulated
, while
and
had up- and down-regulatory effect and
reduced
expression. The
and
reduced
expression. Downregulation of CX3CL1, EPHB6, and TP63 increased
and
, while
downregulation suppressed
and promoted
expression.
We show that
and
are controlled by estradiol, dihydrotestosterone, and miRNAs, as well as modulated by several breast cancer-related genes, which could have future clinical applications.</abstract><cop>United States</cop><pub>Impact Journals LLC</pub><pmid>28977936</pmid><doi>10.18632/oncotarget.19136</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1949-2553 |
ispartof | ONCOTARGET, 2017-09, Vol.8 (37), p.62183-62194 |
issn | 1949-2553 1949-2553 |
language | eng |
recordid | cdi_swepub_primary_oai_swepub_ki_se_493602 |
source | SWEPUB Freely available online; PubMed Central Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central; Free E- Journals |
subjects | Research Paper |
title | The regulation of hydroxysteroid 17β-dehydrogenase type 1 and 2 gene expression in breast cancer cell lines by estradiol, dihydrotestosterone, microRNAs, and genes related to breast cancer |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T00%3A33%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20regulation%20of%20hydroxysteroid%2017%CE%B2-dehydrogenase%20type%201%20and%202%20gene%20expression%20in%20breast%20cancer%20cell%20lines%20by%20estradiol,%20dihydrotestosterone,%20microRNAs,%20and%20genes%20related%20to%20breast%20cancer&rft.jtitle=ONCOTARGET&rft.au=Hilborn,%20Erik&rft.date=2017-09-22&rft.volume=8&rft.issue=37&rft.spage=62183&rft.epage=62194&rft.pages=62183-62194&rft.issn=1949-2553&rft.eissn=1949-2553&rft_id=info:doi/10.18632/oncotarget.19136&rft_dat=%3Cproquest_swepu%3E1947614580%3C/proquest_swepu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1947614580&rft_id=info:pmid/28977936&rfr_iscdi=true |